Development of a Broad-Spectrum Pan-Mpox Vaccine via Immunoinformatic Approaches

Simple item page
dc.contributor.authorJapigorn Puagsopa
dc.contributor.authorPanuwid Jumpalee
dc.contributor.authorSittichoke Dechanun
dc.contributor.authorSukanya Choengchalad
dc.contributor.authorPana Lohasupthawee
dc.contributor.authorThanawat Sutjaritvorakul
dc.contributor.authorBunyarit Meksiriporn
dc.date.accessioned2026-05-08T19:17:03Z
dc.date.issued2025-7-25
dc.description.abstractand was finally cloned in silico into the pET21a (+) vector. Collectively, these results could represent innovative tools for vaccine formulation against MPXV and be transformative for other infectious diseases.
dc.identifier.doi10.3390/ijms26157210
dc.identifier.urihttps://dspace.kmitl.ac.th/handle/123456789/15821
dc.publisherInternational Journal of Molecular Sciences
dc.subjectvaccines and immunoinformatics approaches
dc.subjectPoxvirus research and outbreaks
dc.subjectTransgenic Plants and Applications
dc.titleDevelopment of a Broad-Spectrum Pan-Mpox Vaccine via Immunoinformatic Approaches
dc.typeArticle

Files

Collections

All